Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for Endothelial Function in Metabolic Syndrome
NCT01319344Phase 3Completed
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Sep 2010
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of eplerenone in metabolic syndrome, endothelial dysfunction, sponsored by FAU Erlangen-Nürnberg Medical Faculty. Started Sep 2010; status: completed.
02
Drugs
eplerenone
03
Conditions
metabolic syndromeendothelial dysfunction
Beyond the preview
Go deeper on NCT01319344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01319344.